RSEAX
Price
$17.58
Change
-$0.07 (-0.40%)
Updated
Jul 31 closing price
Net Assets
3.26B
VTSAX
Price
$148.89
Change
-$2.49 (-1.64%)
Updated
Aug 1 closing price
Net Assets
1.91T
Interact to see
Advertisement

RSEAX vs VTSAX

Header iconRSEAX vs VTSAX Comparison
Open Charts RSEAX vs VTSAXBanner chart's image
Russell Inv US Strategic Equity A
Price$17.58
Change-$0.07 (-0.40%)
VolumeN/A
Net Assets3.26B
Vanguard Total Stock Mkt Idx Adm
Price$148.89
Change-$2.49 (-1.64%)
VolumeN/A
Net Assets1.91T
RSEAX vs VTSAX Comparison Chart in %
Loading...
View a ticker or compare two or three
VS
RSEAX vs. VTSAX commentary
Aug 02, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is RSEAX is a Buy and VTSAX is a Buy.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
VTSAX has more cash in the bank: 1.91T vs. RSEAX (3.26B). VTSAX pays higher dividends than RSEAX: VTSAX (1.18) vs RSEAX (0.50). RSEAX was incepted earlier than VTSAX: RSEAX (13 years) vs VTSAX (25 years). RSEAX (1.20) is less costly to investors than VTSAX (0.04). RSEAX is a more actively managed with annual turnover of: 51.00 vs. VTSAX (2.00). RSEAX has a lower initial minimum investment than VTSAX: RSEAX (0) vs VTSAX (3000). VTSAX annual gain was more profitable for investors over the last year : 14.65 vs. RSEAX (2.48). VTSAX return over 5 years is better than : 89.29 vs. RSEAX (39.52).
RSEAXVTSAXRSEAX / VTSAX
Total Expense Ratio1.100.042,750%
Annual Report Gross Expense Ratio1.200.043,000%
Fund Existence13 years25 years-
Gain YTD7.3327.77894%
Front Load6%N/A-
Min. Initial Investment03000-
Min. Initial Investment IRAN/AN/A-
Net Assets3.26B1.91T0%
Annual Yield % from dividends0.501.1842%
Returns for 1 year2.4814.6517%
Returns for 3 years25.8152.1350%
Returns for 5 years39.5289.2944%
Returns for 10 years40.74199.1920%
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
LEICX23.54N/A
N/A
Federated Hermes Equity Income C
NMULX11.20N/A
N/A
Neuberger Berman Multi-Cap Opp I
THISX77.41N/A
N/A
T. Rowe Price Health Sciences I
AVUGX8.23N/A
N/A
American Century Value R5
FEMAX11.74N/A
N/A
First Eagle U.S. SMID Cap Opportunity A